<?xml version='1.0' encoding='utf-8'?>
<document id="31884406"><sentence text="Nobiletin potentiates paclitaxel anticancer efficacy in A549/T xenograft model: Pharmacokinetic and pharmacological study."><entity charOffset="0-9" id="DDI-PubMed.31884406.s1.e0" text="Nobiletin" /><entity charOffset="22-32" id="DDI-PubMed.31884406.s1.e1" text="paclitaxel" /><pair ddi="false" e1="DDI-PubMed.31884406.s1.e0" e2="DDI-PubMed.31884406.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31884406.s1.e0" e2="DDI-PubMed.31884406.s1.e1" /></sentence><sentence text="Nobiletin (N), a polymethoxylated flavone from citrus fruits, enhanced anti-cancer effects of paclitaxel (PTX) in multi-drug resistance (MDR) cancer cells via inhibiting P-glycoprotein (P-gp) in our previous report"><entity charOffset="0-9" id="DDI-PubMed.31884406.s2.e0" text="Nobiletin" /><entity charOffset="11-12" id="DDI-PubMed.31884406.s2.e1" text="N" /><entity charOffset="34-41" id="DDI-PubMed.31884406.s2.e2" text="flavone" /><entity charOffset="94-104" id="DDI-PubMed.31884406.s2.e3" text="paclitaxel" /><entity charOffset="106-109" id="DDI-PubMed.31884406.s2.e4" text="PTX" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e0" e2="DDI-PubMed.31884406.s2.e0" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e0" e2="DDI-PubMed.31884406.s2.e1" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e0" e2="DDI-PubMed.31884406.s2.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e0" e2="DDI-PubMed.31884406.s2.e3" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e0" e2="DDI-PubMed.31884406.s2.e4" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e1" e2="DDI-PubMed.31884406.s2.e1" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e1" e2="DDI-PubMed.31884406.s2.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e1" e2="DDI-PubMed.31884406.s2.e3" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e1" e2="DDI-PubMed.31884406.s2.e4" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e2" e2="DDI-PubMed.31884406.s2.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e2" e2="DDI-PubMed.31884406.s2.e3" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e2" e2="DDI-PubMed.31884406.s2.e4" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e3" e2="DDI-PubMed.31884406.s2.e3" /><pair ddi="false" e1="DDI-PubMed.31884406.s2.e3" e2="DDI-PubMed.31884406.s2.e4" /></sentence><sentence text=" But the in vivo chemo-sensitizing effect of nobiletin is unknown"><entity charOffset="45-54" id="DDI-PubMed.31884406.s3.e0" text="nobiletin" /></sentence><sentence text=" Moreover, considering the nonlinear pharmacokinetics and narrow therapeutic window of PTX, drug-drug interaction should be explored for using nobiletin with PTX together"><entity charOffset="143-152" id="DDI-PubMed.31884406.s4.e0" text="nobiletin" /><entity charOffset="87-95" id="DDI-PubMed.31884406.s4.e1" text="PTX" /><entity charOffset="158-166" id="DDI-PubMed.31884406.s4.e2" text="PTX" /><pair ddi="false" e1="DDI-PubMed.31884406.s4.e1" e2="DDI-PubMed.31884406.s4.e1" /><pair ddi="false" e1="DDI-PubMed.31884406.s4.e1" e2="DDI-PubMed.31884406.s4.e0" /><pair ddi="false" e1="DDI-PubMed.31884406.s4.e1" e2="DDI-PubMed.31884406.s4.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s4.e0" e2="DDI-PubMed.31884406.s4.e0" /><pair ddi="false" e1="DDI-PubMed.31884406.s4.e0" e2="DDI-PubMed.31884406.s4.e2" /></sentence><sentence text="" /><sentence text="In this study, we wanted to explore whether nobiletin could affect the pharmacokinetic (PK) behavior of PTX and reverse drug resistance in vivo as well as the corresponding mechanisms"><entity charOffset="44-53" id="DDI-PubMed.31884406.s6.e0" text="nobiletin" /><entity charOffset="104-112" id="DDI-PubMed.31884406.s6.e1" text="PTX" /><pair ddi="false" e1="DDI-PubMed.31884406.s6.e0" e2="DDI-PubMed.31884406.s6.e0" /><pair ddi="false" e1="DDI-PubMed.31884406.s6.e0" e2="DDI-PubMed.31884406.s6.e1" /></sentence><sentence text="" /><sentence text="Accurate and sensitive UPLC-MS/MS method was developed for the detection of PTX, and was applied to the pharmacokinetic study in rats"><entity charOffset="76-78" id="DDI-PubMed.31884406.s8.e0" text="PTX" /></sentence><sentence text=" In vivo anti-MDR tumor study was carried out with A549/T xenograft nude mice model" /><sentence text=" Immunohistochemistry and western blot analysis were used for evaluating the levels of P-gp, Nrf2, and AKT/ERK pathways in MDR tumors"><entity charOffset="93-95" id="DDI-PubMed.31884406.s10.e0" text="N" /></sentence><sentence text="" /><sentence text="Nobiletin significantly enhanced the therapeutic effects of PTX, and inhibited the MDR tumor sizes in the A549/T xenograft model, while PTX or nobiletin alone did not"><entity charOffset="0-9" id="DDI-PubMed.31884406.s12.e0" text="Nobiletin" /><entity charOffset="143-152" id="DDI-PubMed.31884406.s12.e1" text="nobiletin" /><entity charOffset="60-68" id="DDI-PubMed.31884406.s12.e2" text="PTX" /><entity charOffset="136-144" id="DDI-PubMed.31884406.s12.e3" text="PTX" /><pair ddi="false" e1="DDI-PubMed.31884406.s12.e0" e2="DDI-PubMed.31884406.s12.e0" /><pair ddi="false" e1="DDI-PubMed.31884406.s12.e0" e2="DDI-PubMed.31884406.s12.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s12.e0" e2="DDI-PubMed.31884406.s12.e3" /><pair ddi="false" e1="DDI-PubMed.31884406.s12.e0" e2="DDI-PubMed.31884406.s12.e1" /><pair ddi="false" e1="DDI-PubMed.31884406.s12.e2" e2="DDI-PubMed.31884406.s12.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s12.e2" e2="DDI-PubMed.31884406.s12.e3" /><pair ddi="false" e1="DDI-PubMed.31884406.s12.e2" e2="DDI-PubMed.31884406.s12.e1" /><pair ddi="false" e1="DDI-PubMed.31884406.s12.e3" e2="DDI-PubMed.31884406.s12.e3" /><pair ddi="false" e1="DDI-PubMed.31884406.s12.e3" e2="DDI-PubMed.31884406.s12.e1" /></sentence><sentence text=" We found that nobiletin increased the PTX concentrations in tumor tissues but did not affect the PK behavior of PTX"><entity charOffset="15-24" id="DDI-PubMed.31884406.s13.e0" text="nobiletin" /><entity charOffset="39-47" id="DDI-PubMed.31884406.s13.e1" text="PTX" /><entity charOffset="113-121" id="DDI-PubMed.31884406.s13.e2" text="PTX" /><pair ddi="false" e1="DDI-PubMed.31884406.s13.e0" e2="DDI-PubMed.31884406.s13.e0" /><pair ddi="false" e1="DDI-PubMed.31884406.s13.e0" e2="DDI-PubMed.31884406.s13.e1" /><pair ddi="false" e1="DDI-PubMed.31884406.s13.e0" e2="DDI-PubMed.31884406.s13.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s13.e1" e2="DDI-PubMed.31884406.s13.e1" /><pair ddi="false" e1="DDI-PubMed.31884406.s13.e1" e2="DDI-PubMed.31884406.s13.e2" /></sentence><sentence text=" Notably, Nrf2 and phosphorylation of AKT/ERK expression in MDR tumor tissues were significantly inhibited by giving nobiletin and PTX together"><entity charOffset="117-126" id="DDI-PubMed.31884406.s14.e0" text="nobiletin" /><entity charOffset="1-9" id="DDI-PubMed.31884406.s14.e1" text="N" /><entity charOffset="10-18" id="DDI-PubMed.31884406.s14.e2" text="N" /><entity charOffset="131-139" id="DDI-PubMed.31884406.s14.e3" text="PTX" /><pair ddi="false" e1="DDI-PubMed.31884406.s14.e1" e2="DDI-PubMed.31884406.s14.e1" /><pair ddi="false" e1="DDI-PubMed.31884406.s14.e1" e2="DDI-PubMed.31884406.s14.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s14.e1" e2="DDI-PubMed.31884406.s14.e0" /><pair ddi="false" e1="DDI-PubMed.31884406.s14.e1" e2="DDI-PubMed.31884406.s14.e3" /><pair ddi="false" e1="DDI-PubMed.31884406.s14.e2" e2="DDI-PubMed.31884406.s14.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s14.e2" e2="DDI-PubMed.31884406.s14.e0" /><pair ddi="false" e1="DDI-PubMed.31884406.s14.e2" e2="DDI-PubMed.31884406.s14.e3" /><pair ddi="false" e1="DDI-PubMed.31884406.s14.e0" e2="DDI-PubMed.31884406.s14.e0" /><pair ddi="false" e1="DDI-PubMed.31884406.s14.e0" e2="DDI-PubMed.31884406.s14.e3" /></sentence><sentence text=" However, nobiletin did not affect the expression of P-gp"><entity charOffset="10-19" id="DDI-PubMed.31884406.s15.e0" text="nobiletin" /></sentence><sentence text="" /><sentence text="Nobiletin reversed PTX resistance in MDR tumor via increasing the PTX content in the MDR tumor and inhibiting AKT/ERK/Nrf2 pathways, but without affecting the systematic exposure of PTX, indicating that nobiletin may be an effective and safe MDR tumor reversal agent"><entity charOffset="0-9" id="DDI-PubMed.31884406.s17.e0" text="Nobiletin" /><entity charOffset="203-212" id="DDI-PubMed.31884406.s17.e1" text="nobiletin" /><entity charOffset="118-126" id="DDI-PubMed.31884406.s17.e2" text="N" /><entity charOffset="19-27" id="DDI-PubMed.31884406.s17.e3" text="PTX" /><entity charOffset="66-74" id="DDI-PubMed.31884406.s17.e4" text="PTX" /><entity charOffset="182-190" id="DDI-PubMed.31884406.s17.e5" text="PTX" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e0" e2="DDI-PubMed.31884406.s17.e0" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e0" e2="DDI-PubMed.31884406.s17.e3" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e0" e2="DDI-PubMed.31884406.s17.e4" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e0" e2="DDI-PubMed.31884406.s17.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e0" e2="DDI-PubMed.31884406.s17.e5" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e0" e2="DDI-PubMed.31884406.s17.e1" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e3" e2="DDI-PubMed.31884406.s17.e3" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e3" e2="DDI-PubMed.31884406.s17.e4" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e3" e2="DDI-PubMed.31884406.s17.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e3" e2="DDI-PubMed.31884406.s17.e5" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e3" e2="DDI-PubMed.31884406.s17.e1" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e4" e2="DDI-PubMed.31884406.s17.e4" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e4" e2="DDI-PubMed.31884406.s17.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e4" e2="DDI-PubMed.31884406.s17.e5" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e4" e2="DDI-PubMed.31884406.s17.e1" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e2" e2="DDI-PubMed.31884406.s17.e2" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e2" e2="DDI-PubMed.31884406.s17.e5" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e2" e2="DDI-PubMed.31884406.s17.e1" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e5" e2="DDI-PubMed.31884406.s17.e5" /><pair ddi="false" e1="DDI-PubMed.31884406.s17.e5" e2="DDI-PubMed.31884406.s17.e1" /></sentence><sentence text="" /></document>